{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T19:07:59Z","timestamp":1788376079709,"version":"build-2803163510"},"reference-count":84,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T00:00:00Z","timestamp":1700611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"R\u00e9gion Bretagne-Pays de la Loire"},{"name":"PIRAMID consortium"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microorganisms"],"abstract":"<jats:p>Improving the armamentarium to treat invasive candidiasis has become necessary to overcome drug resistance and the lack of alternative therapy. In the pathogenic fungus Candida albicans, the 90-kDa Heat-Shock Protein (Hsp90) has been described as a major regulator of virulence and resistance, offering a promising target. Some human Hsp90 inhibitors have shown activity against Candida spp. in vitro, but host toxicity has limited their use as antifungal drugs. The conservation of Hsp90 across all species leads to selectivity issues. To assess the potential of Hsp90 as a druggable antifungal target, the activity of nine structurally unrelated Hsp90 inhibitors with different binding domains was evaluated against a panel of Candida clinical isolates. The Hsp90 sequences from human and yeast species were aligned. Despite the degree of similarity between human and yeast N-terminal domain residues, the in vitro activities measured for the inhibitors interacting with this domain were not reproducible against all Candida species. Moreover, the inhibitors binding to the C-terminal domain (CTD) did not show any antifungal activity, with the exception of one of them. Given the greater sequence divergence in this domain, the identification of selective CTD inhibitors of fungal Hsp90 could be a promising strategy for the development of innovative antifungal drugs.<\/jats:p>","DOI":"10.3390\/microorganisms11122837","type":"journal-article","created":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T08:47:43Z","timestamp":1700642863000},"page":"2837","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Is the C-Terminal Domain an Effective and Selective Target for the Design of Hsp90 Inhibitors against Candida Yeast?"],"prefix":"10.3390","volume":"11","author":[{"given":"C\u00e9lia","family":"Rouges","sequence":"first","affiliation":[{"name":"Nantes Universit\u00e9, CHU Nantes, Cibles et M\u00e9dicaments des Infections et de l\u2019Immunit\u00e9, IICiMed, UR 1155, F-44000 Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4425-0664","authenticated-orcid":false,"given":"Mohammad","family":"Asad","sequence":"additional","affiliation":[{"name":"Nantes Universit\u00e9, CNRS, CEISAM, UMR 6230, F-44000 Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9553-9014","authenticated-orcid":false,"given":"Ad\u00e8le D.","family":"Laurent","sequence":"additional","affiliation":[{"name":"Nantes Universit\u00e9, CNRS, CEISAM, UMR 6230, F-44000 Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7773-8642","authenticated-orcid":false,"given":"Pascal","family":"Marchand","sequence":"additional","affiliation":[{"name":"Nantes Universit\u00e9, CHU Nantes, Cibles et M\u00e9dicaments des Infections et de l\u2019Immunit\u00e9, IICiMed, UR 1155, F-44000 Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5059-6402","authenticated-orcid":false,"given":"Patrice","family":"Le Pape","sequence":"additional","affiliation":[{"name":"Nantes Universit\u00e9, CHU Nantes, Cibles et M\u00e9dicaments des Infections et de l\u2019Immunit\u00e9, IICiMed, UR 1155, F-44000 Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,11,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1056\/NEJMoa1801550","article-title":"Changes in Prevalence of Health Care\u2013Associated Infections in U.S. Hospitals","volume":"379","author":"Magill","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1128\/AAC.01128-10","article-title":"Recent Exposure to Caspofungin or Fluconazole Influences the Epidemiology of Candidemia: A Prospective Multicenter Study Involving 2441 Patients","volume":"55","author":"Lortholary","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2011.11.001","article-title":"Antifungal Drug Resistance: Mechanisms, Epidemiology, and Consequences for Treatment","volume":"125","author":"Pfaller","year":"2012","journal-title":"Am. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/cid\/cit136","article-title":"Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations","volume":"56","author":"Alexander","year":"2013","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.15585\/mmwr.mm6901a2","article-title":"Candida Auris Isolates Resistant to Three Classes of Antifungal Medications\u2014New York, 2019","volume":"69","author":"Ostrowsky","year":"2020","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41579-022-00720-1","article-title":"Tackling the Emerging Threat of Antifungal Resistance to Human Health","volume":"20","author":"Fisher","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Chen, B., Zhong, D., and Monteiro, A. (2006). Comparative Genomics and Evolution of the HSP90 Family of Genes across All Kingdoms of Organisms. BMC Genom., 7.","DOI":"10.1186\/1471-2164-7-156"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S1097-2765(03)00065-0","article-title":"Structural and Functional Analysis of the Middle Segment of Hsp90: Implications for ATP Hydrolysis and Client Protein and Cochaperone Interactions","volume":"11","author":"Meyer","year":"2003","journal-title":"Mol. Cell"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"4943","DOI":"10.1016\/S0021-9258(19)67740-9","article-title":"The 90-Kda Heat Shock Protein (Hsp-90) Possesses an ATP Binding Site and Autophosphorylating Activity","volume":"266","author":"Csermely","year":"1991","journal-title":"J. Biol. Chem."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nrm.2017.20","article-title":"The HSP90 Chaperone Machinery","volume":"18","author":"Schopf","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.bbamcr.2011.10.008","article-title":"Advances in the Clinical Development of Heat Shock Protein 90 (Hsp90) Inhibitors in Cancers","volume":"1823","author":"Jhaveri","year":"2012","journal-title":"Biochim. Biophys. Acta BBA Mol. Cell Res."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Bohush, A., Bieganowski, P., and Filipek, A. (2019). Hsp90 and Its Co-Chaperones in Neurodegenerative Diseases. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20204976"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.bbamcr.2011.11.007","article-title":"Broad Action of Hsp90 as a Host Chaperone Required for Viral Replication","volume":"1823","author":"Geller","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1051\/parasite\/2017023","article-title":"The Heat Shock Protein 90 of Toxoplasma Gondii Is Essential for Invasion of Host Cells and Tachyzoite Growth","volume":"24","author":"Sun","year":"2017","journal-title":"Parasite"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1038\/sj.onc.1201790","article-title":"Targeting of the Protein Chaperone, HSP90, by the Transformation Suppressing Agent, Radicicol","volume":"16","author":"Sharma","year":"1998","journal-title":"Oncogene"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"5117","DOI":"10.1021\/jo4002849","article-title":"Learning from Nature: Advances in Geldanamycin- and Radicicol-Based Inhibitors of Hsp90","volume":"78","author":"Kitson","year":"2013","journal-title":"J. Org. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.2174\/092986708786242895","article-title":"Novobiocin and Additional Inhibitors of the Hsp90 C-Terminal Nucleotide-Binding Pocket","volume":"15","author":"Donnelly","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1016\/j.bmcl.2010.12.088","article-title":"Identification and Initial SAR of Silybin: An Hsp90 Inhibitor","volume":"21","author":"Zhao","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/jnci\/djm007","article-title":"Structural Basis for Depletion of Heat Shock Protein 90 Client Proteins by Deguelin","volume":"99","author":"Oh","year":"2007","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Nguyen, C.-T., Ann, J., Sahu, R., Byun, W.S., Lee, S., Nam, G., Park, H.-J., Park, S., Kim, Y.-J., and Kim, J.Y. (2020). Discovery of Novel Anti-Breast Cancer Agents Derived from Deguelin as Inhibitors of Heat Shock Protein 90 (HSP90). Bioorg. Med. Chem. Lett., 30.","DOI":"10.1016\/j.bmcl.2020.127374"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1158\/1940-6207.CAPR-14-0224","article-title":"The Heat Shock Protein 90 Inhibitor, Epigallocatechin Gallate, Has Anti-Cancer Activity in a Novel Human Prostate Cancer Progression Model","volume":"8","author":"Moses","year":"2015","journal-title":"Cancer Prev. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1126\/science.1118370","article-title":"Hsp90 Potentiates the Rapid Evolution of New Traits: Drug Resistance in Diverse Fungi","volume":"309","author":"Cowen","year":"2005","journal-title":"Science"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.tim.2017.05.003","article-title":"The Hsp90 Chaperone Network Modulates Candida Virulence Traits","volume":"25","author":"Robbins","year":"2017","journal-title":"Trends Microbiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e02529-18","DOI":"10.1128\/mBio.02529-18","article-title":"Genetic Analysis of Candida auris Implicates Hsp90 in Morphogenesis and Azole Tolerance and Cdr1 in Azole Resistance","volume":"10","author":"Kim","year":"2019","journal-title":"mBio"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"392","DOI":"10.7883\/yoken.JJID.2009.392","article-title":"The Effects of an Hsp90 Inhibitor on the Paradoxical Effect","volume":"62","author":"Kaneko","year":"2009","journal-title":"Jpn. J. Infect. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Singh-Babak, S.D., Babak, T., Diezmann, S., Hill, J.A., Xie, J.L., Chen, Y.-L., Poutanen, S.M., Rennie, R.P., Heitman, J., and Cowen, L.E. (2012). Global Analysis of the Evolution and Mechanism of Echinocandin Resistance in Candida Glabrata. PloS Pathog., 8.","DOI":"10.1371\/journal.ppat.1002718"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41467-018-08248-w","article-title":"Structural Basis for Species-Selective Targeting of Hsp90 in a Pathogenic Fungus","volume":"10","author":"Whitesell","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_28","first-page":"2589","article-title":"The Non-Geldanamycin Hsp90 Inhibitors Enhanced the Antifungal Activity of Fluconazole","volume":"7","author":"Li","year":"2015","journal-title":"Am. J. Transl. Res."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Singh, S.D., Robbins, N., Zaas, A.K., Schell, W.A., Perfect, J.R., and Cowen, L.E. (2009). Hsp90 Governs Echinocandin Resistance in the Pathogenic Yeast Candida Albicans via Calcineurin. PloS Pathog., 5.","DOI":"10.1371\/journal.ppat.1000532"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s11046-012-9612-1","article-title":"Antifungal Activity of Geldanamycin Alone or in Combination with Fluconazole against Candida Species","volume":"175","author":"Zhang","year":"2013","journal-title":"Mycopathologia"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s11046-019-00370-7","article-title":"In Vitro Interaction of Geldanamycin with Triazoles and Echinocandins Against Common and Emerging Candida Species","volume":"184","author":"Mahmoudi","year":"2019","journal-title":"Mycopathologia"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1073\/pnas.0813394106","article-title":"Harnessing Hsp90 Function as a Powerful, Broadly Effective Therapeutic Strategy for Fungal Infectious Disease","volume":"106","author":"Cowen","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Rakelly de Oliveira, D., Relison Tintino, S., Morais Braga, M.F.B., Boligon, A.A., Linde Athayde, M., Douglas Melo Coutinho, H., de Menezes, I.R.A., and Fachinetto, R. (2015). In Vitro Antimicrobial and Modulatory Activity of the Natural Products Silymarin and Silibinin. BioMed Res. Int., 2015.","DOI":"10.1155\/2015\/292797"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/mmy\/myu073","article-title":"In Vitro Activity of 23 Tea Extractions and Epigallocatechin Gallate against Candida Species","volume":"53","author":"Chen","year":"2015","journal-title":"Med. Mycol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.mycmed.2019.01.011","article-title":"Synergistic Effects of Tea Polyphenol Epigallocatechin 3-O-Gallate and Azole Drugs against Oral Candida Isolates","volume":"29","author":"Behbehani","year":"2019","journal-title":"J. Mycol. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1021\/acs.jmedchem.0c01777","article-title":"Fungal-Selective Resorcylate Aminopyrazole Hsp90 Inhibitors: Optimization of Whole-Cell Anticryptococcal Activity and Insights into the Structural Origins of Cryptococcal Selectivity","volume":"64","author":"Marcyk","year":"2021","journal-title":"J. Med. Chem."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"5539","DOI":"10.1021\/acs.jmedchem.1c01991","article-title":"Species-Selective Targeting of Fungal Hsp90: Design, Synthesis, and Evaluation of Novel 4,5-Diarylisoxazole Derivatives for the Combination Treatment of Azole-Resistant Candidiasis","volume":"65","author":"Yin","year":"2022","journal-title":"J. Med. Chem."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Garcia-Rubio, R., de Oliveira, H.C., Rivera, J., and Trevijano-Contador, N. (2020). The Fungal Cell Wall: Candida, Cryptococcus, and Aspergillus Species. Front. Microbiol., 10.","DOI":"10.3389\/fmicb.2019.02993"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1128\/AAC.01486-12","article-title":"Elevated Chitin Content Reduces the Susceptibility of Candida Species to Caspofungin","volume":"57","author":"Walker","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1111\/j.1462-5822.2012.01813.x","article-title":"Host Carbon Sources Modulate Cell Wall Architecture, Drug Resistance and Virulence in a Fungal Pathogen","volume":"14","author":"Ene","year":"2012","journal-title":"Cell. Microbiol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Chew, S.Y., Ho, K.L., Cheah, Y.K., Sandai, D., Brown, A.J.P., and Than, L.T.L. (2019). Physiologically Relevant Alternative Carbon Sources Modulate Biofilm Formation, Cell Wall Architecture, and the Stress and Antifungal Resistance of Candida glabrata. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20133172"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e02383-17","DOI":"10.1128\/mBio.02383-17","article-title":"The Viscoelastic Properties of the Fungal Cell Wall Allow Traffic of AmBisome as Intact Liposome Vesicles","volume":"9","author":"Walker","year":"2018","journal-title":"mBio"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Walker, L.A., and Munro, C.A. (2020). Caspofungin Induced Cell Wall Changes of Candida Species Influences Macrophage Interactions. Front. Cell. Infect. Microbiol., 10.","DOI":"10.3389\/fcimb.2020.00164"},{"key":"ref_44","first-page":"86","article-title":"Isolation and Partial Characterization of Hsp90 from Candida Albicans","volume":"33","author":"Burt","year":"2003","journal-title":"Ann. Clin. Lab. Sci."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Galocha, M., Costa, I.V., and Teixeira, M.C. (2020). Carrier-Mediated Drug Uptake in Fungal Pathogens. Genes, 11.","DOI":"10.3390\/genes11111324"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.diagmicrobio.2009.11.006","article-title":"Screening for Amino Acid Substitutions in the Candida Albicans Erg11 Protein of Azole-Susceptible and Azole-Resistant Clinical Isolates: New Substitutions and a Review of the Literature","volume":"66","author":"Morio","year":"2010","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1093\/jac\/dkz565","article-title":"Impact of Calmodulin Inhibition by Fluphenazine on Susceptibility, Biofilm Formation and Pathogenicity of Caspofungin-Resistant Candida glabrata","volume":"75","author":"Amado","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_48","first-page":"79","article-title":"A New Automatized Fluorometric Assay for Anti-Leishmania Drug Screening","volume":"47","author":"Pape","year":"2002","journal-title":"Acta Parasitol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"W320","DOI":"10.1093\/nar\/gku316","article-title":"Deciphering Key Features in Protein Structures with the New ENDscript Server","volume":"42","author":"Robert","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0021-9258(18)65573-5","article-title":"Antagonists of Nucleic Acid Derivatives. VIII Synergism in Combinations of Biochemically Related Antimetabolites","volume":"208","author":"Elion","year":"1954","journal-title":"J. Biol. Chem."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg301","article-title":"Synergy, Antagonism, and What the Chequerboard Puts between Them","volume":"52","author":"Odds","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: A Free Web Tool to Evaluate Pharmacokinetics, Drug-Likeness and Medicinal Chemistry Friendliness of Small Molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Xu, D., Jiang, B., Ketela, T., Lemieux, S., Veillette, K., Martel, N., Davison, J., Sillaots, S., Trosok, S., and Bachewich, C. (2007). Genome-Wide Fitness Test and Mechanism-of-Action Studies of Inhibitory Compounds in Candida Albicans. PLoS Pathog., 3.","DOI":"10.1371\/journal.ppat.0030092"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Mansfield, B.E., Oltean, H.N., Oliver, B.G., Hoot, S.J., Leyde, S.E., Hedstrom, L., and White, T.C. (2010). Azole Drugs Are Imported By Facilitated Diffusion in Candida Albicans and Other Pathogenic Fungi. PLoS Pathog., 6.","DOI":"10.1371\/journal.ppat.1001126"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1093\/infdis\/jit358","article-title":"Pharmacokinetics of Posaconazole Within Epithelial Cells and Fungi: Insights Into Potential Mechanisms of Action During Treatment and Prophylaxis","volume":"208","author":"Campoli","year":"2013","journal-title":"J. Infect. Dis."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/nature04716","article-title":"Crystal Structure of an Hsp90-Nucleotide-P23\/Sba1 Closed Chaperone Complex","volume":"440","author":"Ali","year":"2006","journal-title":"Nature"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/abbs\/gms001","article-title":"Structure Insights into Mechanisms of ATP Hydrolysis and the Activation of Human Heat-Shock Protein 90","volume":"44","author":"Li","year":"2012","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0092-8674(00)80203-2","article-title":"Crystal Structure of an Hsp90-Geldanamycin Complex: Targeting of a Protein Chaperone by an Antitumor Agent","volume":"89","author":"Stebbins","year":"1997","journal-title":"Cell"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1096\/fj.11-188821","article-title":"Features of the Streptomyces Hygroscopicus HtpG Reveal How Partial Geldanamycin Resistance Can Arise with Mutation to the ATP Binding Pocket of a Eukaryotic Hsp90","volume":"25","author":"Millson","year":"2011","journal-title":"FASEB J."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1021\/jm980403y","article-title":"Structural Basis for Inhibition of the Hsp90 Molecular Chaperone by the Antitumor Antibiotics Radicicol and Geldanamycin","volume":"42","author":"Roe","year":"1999","journal-title":"J. Med. Chem."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1177\/1087057112445785","article-title":"Fragment Screening Using Capillary Electrophoresis (CEfrag) for Hit Identification of Heat Shock Protein 90 ATPase Inhibitors","volume":"17","author":"Austin","year":"2012","journal-title":"J. Biomol. Screen."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1021\/jm701018h","article-title":"4,5-Diarylisoxazole Hsp90 Chaperone Inhibitors: Potential Therapeutic Agents for the Treatment of Cancer","volume":"51","author":"Brough","year":"2008","journal-title":"J. Med. Chem."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.bmcl.2013.11.036","article-title":"Correlation between Chemotype-Dependent Binding Conformations of HSP90\u03b1\/\u03b2 and Isoform Selectivity-Implications for the Structure-Based Design of HSP90\u03b1\/\u03b2 Selective Inhibitors for Treating Neurodegenerative Diseases","volume":"24","author":"Ernst","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Pizarro, J.C., Hills, T., Senisterra, G., Wernimont, A.K., Mackenzie, C., Norcross, N.R., Ferguson, M.A.J., Wyatt, P.G., Gilbert, I.H., and Hui, R. (2013). Exploring the Trypanosoma Brucei Hsp83 Potential as a Target for Structure Guided Drug Design. PLoS Negl. Trop. Dis., 7.","DOI":"10.1371\/journal.pntd.0002492"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"7786","DOI":"10.1021\/jm300810x","article-title":"EC144 Is a Potent Inhibitor of the Heat Shock Protein 90","volume":"55","author":"Shi","year":"2012","journal-title":"J. Med. Chem."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1016\/j.molcel.2021.07.023","article-title":"The Structure of an Hsp90-Immunophilin Complex Reveals Cochaperone Recognition of the Client Maturation State","volume":"81","author":"Lee","year":"2021","journal-title":"Mol. Cell"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly Accurate Protein Structure Prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"D439","DOI":"10.1093\/nar\/gkab1061","article-title":"AlphaFold Protein Structure Database: Massively Expanding the Structural Coverage of Protein-Sequence Space with High-Accuracy Models","volume":"50","author":"Varadi","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1747-0285.2008.00650.x","article-title":"Structural Models and Binding Site Prediction of the C-Terminal Domain of Human Hsp90: A New Target for Anticancer Drugs","volume":"71","author":"Sgobba","year":"2008","journal-title":"Chem. Biol. Drug Des."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1021\/ci1001857","article-title":"Exploring the Binding Site of C-Terminal Hsp90 Inhibitors","volume":"50","author":"Sgobba","year":"2010","journal-title":"J. Chem. Inf. Model."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1021\/cb200052x","article-title":"Elucidation of the Hsp90 C-Terminal Inhibitor Binding Site","volume":"6","author":"Matts","year":"2011","journal-title":"ACS Chem. Biol."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Cuy\u00e0s, E., Verdura, S., Micol, V., Joven, J., Bosch-Barrera, J., Encinar, J.A., and Menendez, J.A. (2019). Revisiting Silibinin as a Novobiocin-like Hsp90 C-Terminal Inhibitor: Computational Modeling and Experimental Validation. Food Chem. Toxicol. Int. J. Publ. Br. Ind. Biol. Res. Assoc., 132.","DOI":"10.1016\/j.fct.2019.110645"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.2741\/4050","article-title":"Geldanamycin and Its Derivatives as Hsp90 Inhibitors","volume":"17","author":"Gorska","year":"2012","journal-title":"Front. Biosci. Landmark Ed."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Shen, C.-H., Hsieh, C.-C., Jiang, K.-Y., Lin, C.-Y., Chiang, N.-J., Li, T.-W., Yen, C.-T., Chen, W.-J., Hwang, D.-Y., and Chen, L.-T. (2021). AUY922 Induces Retinal Toxicity through Attenuating TRPM1. J. Biomed. Sci., 28.","DOI":"10.1186\/s12929-021-00751-5"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1046\/j.1432-1033.2003.03610.x","article-title":"Comparative Analysis of the ATP-Binding Sites of Hsp90 by Nucleotide Affinity Cleavage: A Distinct Nucleotide Specificity of the C-Terminal ATP-Binding Site","volume":"270","author":"Soti","year":"2003","journal-title":"Eur. J. Biochem."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Negri, A., Naponelli, V., Rizzi, F., and Bettuzzi, S. (2018). Molecular Targets of Epigallocatechin\u2014Gallate (EGCG): A Special Focus on Signal Transduction and Cancer. Nutrients, 10.","DOI":"10.3390\/nu10121936"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.ijantimicag.2013.07.013","article-title":"Deciphering Azole Resistance Mechanisms with a Focus on Transcription Factor-Encoding Genes TAC1, MRR1 and UPC2 in a Set of Fluconazole-Resistant Clinical Isolates of Candida albicans","volume":"42","author":"Morio","year":"2013","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.3390\/ph4111400","article-title":"Mechanisms of Resistance to Hsp90 Inhibitor Drugs: A Complex Mosaic Emerges","volume":"4","author":"Piper","year":"2011","journal-title":"Pharmaceuticals"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1021\/mp900037p","article-title":"(-)-Epigallocatechin-3-gallate inhibits Hsp90 function by impairing Hsp90 association with cochaperones in pancreatic cancer cell line Mia Paca-2","volume":"6","author":"Li","year":"2009","journal-title":"Mol. Pharm."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Kim, H.J., Lee, K.Y., Kim, Y.W., Choi, Y.J., Lee, J.-E., Choi, C.M., Baek, I.-J., Rho, J.K., and Lee, J.C. (2015). P-Glycoprotein Confers Acquired Resistance to 17-DMAG in Lung Cancers with an ALK Rearrangement. BMC Cancer, 15.","DOI":"10.1186\/s12885-015-1543-z"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1002\/ijc.24825","article-title":"BIIB021, a Synthetic Hsp90 Inhibitor, Has Broad Application against Tumors with Acquired Multidrug Resistance","volume":"126","author":"Zhang","year":"2010","journal-title":"Int. J. Cancer"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0167-4889(01)00175-6","article-title":"Inhibition of the Multidrug Resistance P-Glycoprotein Activity by Green Tea Polyphenols","volume":"1542","author":"Jodoin","year":"2002","journal-title":"Biochim. Biophys. Acta BBA Mol. Cell Res."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Dini\u0107, J., Podolski-Reni\u0107, A., Jovanovi\u0107, M., Musso, L., Tsakovska, I., Pajeva, I., Dallavalle, S., and Pe\u0161i\u0107, M. (2019). Novel Heat Shock Protein 90 Inhibitors Suppress P-Glycoprotein Activity and Overcome Multidrug Resistance in Cancer Cells. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20184575"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.chembiol.2021.03.016","article-title":"Discovery of a covalent inhibitor of heat shock protein 90 with antitumor activity that blocks the co-chaperone binding via C-terminal modification","volume":"28","author":"Li","year":"2021","journal-title":"Cell Chem. Biol."}],"container-title":["Microorganisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2607\/11\/12\/2837\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:27:23Z","timestamp":1760131643000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2607\/11\/12\/2837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,22]]},"references-count":84,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["microorganisms11122837"],"URL":"https:\/\/doi.org\/10.3390\/microorganisms11122837","relation":{},"ISSN":["2076-2607"],"issn-type":[{"value":"2076-2607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,22]]}}}